Tackling the complex development landscape of pain medicines
European Pharmaceutical Review
JANUARY 11, 2024
chronic neuropathic pain is at present, mainly managed with antidepressants… antiepileptic drugs… as well as opioids” Neuropathic pain affects over 400 million people worldwide, according to Hoba Therapeutics. In Europe, the prevalence of chronic neuropathic pain is estimated to be six–eight percent 1 of the general population.
Let's personalize your content